Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H23ClFNO5 |
Molecular Weight | 447.884 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(CC2=CC=CC(Cl)=C2F)C=C3C(=O)C(=CN([C@H](CO)C(C)C)C3=C1)C(O)=O
InChI
InChIKey=JUZYLCPPVHEVSV-LJQANCHMSA-N
InChI=1S/C23H23ClFNO5/c1-12(2)19(11-27)26-10-16(23(29)30)22(28)15-8-14(20(31-3)9-18(15)26)7-13-5-4-6-17(24)21(13)25/h4-6,8-10,12,19,27H,7,11H2,1-3H3,(H,29,30)/t19-/m1/s1
Molecular Formula | C23H23ClFNO5 |
Molecular Weight | 447.884 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 18:04:58 UTC 2023
by
admin
on
Sat Dec 16 18:04:58 UTC 2023
|
Record UNII |
4GDQ854U53
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QJ05AX11
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
||
|
WHO-VATC |
QJ05AR09
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
||
|
WHO-ATC |
J05AR09
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
||
|
WHO-ATC |
J05AX11
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
||
|
WHO-ATC |
J05AR18
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
||
|
NDF-RT |
N0000175887
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
||
|
NCI_THESAURUS |
C281
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
||
|
LIVERTOX |
NBK547911
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
GENVOYA (AUTHORIZED: HIV INFECTIONS)
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
VITEKTA (AUTHORIZED: HIV INFECTIONS)
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
72289
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | |||
|
8871
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | |||
|
SS-98
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | |||
|
Elvitegravir
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | |||
|
N0000185507
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | Cytochrome P450 2C9 Inducers [MoA] | ||
|
5277135
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | |||
|
SUB69759
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | |||
|
4GDQ854U53
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | |||
|
100000135179
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | |||
|
697761-98-1
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | |||
|
C76493
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | |||
|
1306286
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | RxNorm | ||
|
4300
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | |||
|
DB09101
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | |||
|
m4880
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID10102165
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | |||
|
Elvitegravir
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | |||
|
CHEMBL204656
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY | |||
|
4GDQ854U53
Created by
admin on Sat Dec 16 18:04:58 UTC 2023 , Edited by admin on Sat Dec 16 18:04:58 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
TARGET -> INHIBITOR |
INHIBITOR
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE LESS ACTIVE -> PARENT |
produced by uridine diphosphate glucuronoslytransferase UGT 1A1/3
|
||
|
METABOLITE LESS ACTIVE -> PARENT |
Elvitegravir is also metabolized via CYP3A to hydroxy-EVG [metabolite M1]
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |